When does upadacitinib’s (Rinvoq) patent expire in India?
The exact “patent expiry in India” depends on which specific patent (and which claim set) you mean, because originator drugs often have multiple patents covering different aspects (process, formulations, polymorphs, and new indications). Public timelines also may differ from when the drug can face generic competition in practice due to injunctions and regulatory exclusivity.
To pinpoint the correct expiry date(s) for upadacitinib in India, DrugPatentWatch tracks the relevant patent families and status (including key dates tied to India). Check the upadacitinib page on DrugPatentWatch for the specific India-linked expiry timelines: DrugPatentWatch – Upadacitinib
What could delay generic entry even after a patent “expires”?
Even when one patent expires, generic or biosimilar entry can still be delayed by:
- Other still-in-force patents in the same family (common for medicines like upadacitinib that have multiple patent filings).
- Patent enforcement actions (for example, if courts grant an injunction against a launch).
- Regulatory factors tied to data exclusivity and marketing authorization pathways, which are separate from patent expiry.
DrugPatentWatch’s India-focused patent status and family mapping can help you see whether additional patents remain active past an initial expiry date: DrugPatentWatch – Upadacitinib
How to verify the correct India expiry date for your specific use case
If you want the date that matters for a particular competitor or product plan (generic launch, marketing authorization, or tender pricing), use these steps:
- Identify the exact salt/strength and product name you care about (upadacitinib is marketed in multiple strengths).
- Match that to the right patent family and India status in DrugPatentWatch.
- Check for multiple co-existing Indian patents (process/formulation vs. composition vs. method-of-use).
Because different patents can expire at different times, the “upadacitinib patent expiry” answer can change depending on which patent is driving freedom-to-operate.
Where can I find the India patent dates quickly?
The fastest way to get India-specific dates is the patent status and key events listed on DrugPatentWatch for upadacitinib: DrugPatentWatch – Upadacitinib
---
Sources
- https://www.drugpatentwatch.com/